What's new at PolyPeptide? Things are happening all the time!
If you need more information about our company, you can discover our new corporate brochure or watch our latest video.
The PolyPeptide Group appointed to manufacture Scancell’s Modi-1-AMPLIVANT® conjugate
"Scancell Holdings plc, (‘Scancell’ or the ‘Company’), the developer of novel immunotherapies for the treatment of cancer, is pleased to announce that it signed an agreement at the end of March 2018 with The PolyPeptide Group, one of the world’s largest independent contract manufacturers of therapeutic peptides, for Good Manufacturing Practice (GMP) manufacture of its first Moditope® development candidate, Modi-1 - AMPLIVANT® conjugate."